サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1226794

中南米の左室補助装置市場の2028年までの予測- 地域別分析- フロータイプ、設計、アプリケーション

South & Central America Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - Type of Flow, Design, and Application
出版日: | 発行: The Insight Partners | ページ情報: 英文 96 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
中南米の左室補助装置市場の2028年までの予測- 地域別分析- フロータイプ、設計、アプリケーション
出版日: 2023年01月25日
発行: The Insight Partners
ページ情報: 英文 96 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の左室補助装置市場は、2022年の1億2,576万米ドルから2028年には1億6,202万米ドルに成長すると予測されています。2022年から2028年までのCAGRは4.3%を記録すると推定されています。

中南米の左室補助装置市場は、新興国の未開拓の可能性が今後の市場成長を促進します。

アルゼンチンやブラジルなどの新興国は、患者数の増加、研究開発活動の活発化、CVDに対する意識の高まり、可処分所得の急増、ヘルスケアインフラの改善、先進国に比べて比較的緩やかな政策などにより、LVAD市場の企業に大きな成長機会を提供すると期待されています。また、新興国では過去10年間、心不全患者の増加が続いています。世界経済フォーラムによると、ブラジル、ロシア、インド、中国、南アフリカは2017年時点で世界で最も急速に成長している経済圏の一つであり、2022年までに世界の医療費総額の3分の1を占めると予想されています。アルゼンチンでは、2019年12月に左室非コンパクションの既往歴があり、重度の左室機能障害を有する52歳の患者に対してHeartMate 3 HM3（アボットラボラトリーズ社製）の移植が実践されました。新興国市場では、ヘルスケア支出の増加や対象患者数の増加により、病院や手術センターの数が増加することが予想されます。したがって、中南米の新興経済諸国におけるヘルスケア施設の整備と病院数の急増は、今後数年間におけるLVADの採用を促進すると考えられます。さらに、老舗企業間の競争激化により、新興市場に注力せざるを得なくなり、中南米の左室補助装置市場に今後さらなる成長の道を開くと予想されます。

中南米の左室補助装置市場の概要

中南米の左室補助装置市場は、ブラジル、アルゼンチン、その他南米で構成されています。中南米の左室補助装置市場は、ブラジルが最大のシェアを占めています。医療観光の盛んな地域と、最新のヘルスケア製品に関する認識を高めるための政府の取り組みが、中南米における左室補助装置市場の成長に寄与する要因となっています。また、心血管疾患、高血圧、脳卒中の有病率が上昇していることも、同地域における左室補助装置への需要を後押ししています。Sociedade Brasileira de Cardiologia（SBC）が発表したレポートによると、ブラジルでは心不全（HF）がCVDに関連した入院の主な原因であり、これらの人の50％の人口のうち～1～2％は駆出率が低下しています。しかも、これらの患者の多くは標準的な治療や入院に消極的で、最初の入院から6ヵ月以内に死亡または再入院する割合は～50％にものぼります。左室補助装置は、連続流装置とも呼ばれ、患者の心臓から身体への血液の流れを一定に保つことができます。左室補助循環装置の需要は、先進国で報告されている数字とは異なり、ブラジルではかなり低いです。LVDの移植を受けた患者の生存率とQOLの向上が証明されているにもかかわらず、治療にかかる直接的・間接的なコストは依然として高い水準にあります。また、移植手術に伴う合併症が、ブラジルにおけるLVADの需要を妨げています。

中南米の左室補助装置市場の収益と2028年までの予測（金額）

中南米の左室補助装置市場のセグメンテーション

中南米の左室補助装置市場は、流れの種類、デザイン、用途、国別に区分されます。

流れのタイプに基づき、中南米の左室補助装置市場は、非脈動性と脈動性に区分されます。非脈動性セグメントは、2022年に最大の市場シェアを登録しました。

デザインに基づき、中南米の左室補助装置市場は、植え込み型心室補助装置と経皮型心室補助装置に二分されます。植え込み型心室補助装置セグメントは、2022年に最大の市場シェアを登録しました。

用途に基づき、中南米の左室補助装置市場は、目的地治療、移植への橋渡し、候補地への橋渡し、回復への橋渡しに区分されます。2022年には、目的地治療分野が最大の市場シェアを記録しました。

中南米の左室補助装置市場は、国別では、ブラジル、アルゼンチン、その他南米に区分されます。2022年の市場シェアはブラジルが圧倒的に多いです。

ABIOMED Inc、Abbott Laboratories、Medtronic Plc、LivaNova Plc、およびEvaheart Incは、南＆中米の左室補助装置市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 中南米の左室補助装置市場- 市場展望

  • PEST分析
  • 専門家の見解

第5章 中南米の左室補助装置市場- 主要市場力学

  • 市場促進要因
    • 対象疾患と手術の発生率の増加
  • 市場抑制要因
    • 左室補助装置に関連する製品回収と合併症の増加
  • 市場機会
    • 新興国における未開発のポテンシャル
  • 今後の動向
    • LVADにおける人工知能と機械学習の利用拡大
  • 影響度分析

第6章 中南米の左室補助装置市場分析

  • 中南米の左室補助装置市場の収益と予測・分析

第7章 中南米の左室補助装置市場分析：フロータイプ別

  • 中南米の左室補助装置市場：フロータイプ別2021年・2028年（%）
  • 拍動性フロー
  • 非脈動性

第8章 中南米左室補助装置の市場分析：設計別

  • 中南米の左室補助装置市場：設計別2021年・2028年（%）
  • 植込み型心室補助装置
  • 経皮的心室補助装置

第9章 中南米の左室補助装置市場分析：アプリケーション別

  • 中南米の左室補助装置市場：アプリケーション別2021年・2028年（%）
  • BTT
  • DT
  • BTR
  • BTC

第10章 中南米の左室補助装置市場：国別分析

    • 中南米地域
      • ブラジル
      • アルゼンチン
      • その他中南米地域

第11章 企業プロファイル

  • ABIOMED Inc
  • Abbott Laboratories
  • Medtronic Plc
  • LivaNova Plc
  • Terumo Corp
  • BioVentrix Inc

第12章 付録

図表

List Of Tables

  • Table 1. Brazil Left Ventricular Assist Device Market, by Type of Flow- Revenue and Forecasts to 2028 (US$ Million)
  • Table 2. Brazil Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Brazil: Left Ventricular Assist Device Market, by Application - Revenue and Forecasts to 2028(US$ Million)
  • Table 4. Argentina: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecasts to 2028 (US$ Million)
  • Table 5. Argentina: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Argentina: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Rest of South & Central America: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Rest of South & Central America: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Rest of South & Central America Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Glossary of Terms

List Of Figures

  • Figure 1. South & Central America Left Ventricular Assist Device Market Segmentation
  • Figure 2. South & Central America Left Ventricular Assist Device Market, By Country
  • Figure 3. South & Central America Left Ventricular Assist Device Market Overview
  • Figure 4. Implantable Ventricular Assist Device Held Largest Share for Design Segment in Left Ventricular Assist Device Market
  • Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. Impact Analysis
  • Figure 9. South & Central America Left Ventricular Assist Device Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. South & Central America Left Ventricular Assist Device Market, by Type of Flow 2021 & 2028 (%)
  • Figure 11. Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 12. Non-Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 13. South & Central America Left Ventricular Assist Device Market, by Design 2021 & 2028 (%)
  • Figure 14. Implantable Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 15. Transcutaneous Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 16. South & Central America Left Ventricular Assist Device Market, by Application 2021 & 2028 (%)
  • Figure 17. Bridge to Transplantation Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 18. Destination Therapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 19. Bridge to Recovery Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 20. Bridge to Candidacy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 21. South & Central America Left Ventricular Assist Device Market Revenue Overview, by Country, 2022 (US$ Million)
  • Figure 22. South & Central America: Left Ventricular Assist Device Market, by Country, 2022 & 2028 (%)
  • Figure 23. Brazil: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Argentina: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Rest of the South & Central America: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00027966

The South & Central America left ventricular assist device market is expected to grow from US$ 125.76 million in 2022 to US$ 162.02 million by 2028. It is estimated to record a CAGR of 4.3% from 2022 to 2028.

Untapped Potential in Emerging Economies to Propel Market Growth in Coming Years of the South & Central America left ventricular assist device market

Emerging countries such as Argentina and Brazil are expected to offer significant growth opportunities to companies in the LVAD market mainly due to their rising patient population, increasing R&D activities, growing CVD awareness, surging disposable incomes, improving healthcare infrastructure, and comparatively lenient policies compared to developed countries. Also, emerging markets have seen a sustained increase in heart failure cases over the past decade. According to the World Economic Forum, Brazil, Russia, India, China, and South Africa were among the fastest-growing economies globally as of 2017 and are expected to account for a third of total global health spending by 2022. In Argentina, the implantation of a HeartMate 3 HM3 (manufactured by Abbott Laboratories) was practiced on a 52-year-old patient with a history of left ventricular noncompaction and severe left ventricular dysfunction in December 2019. The number of hospitals and surgical centers in emerging markets is expected to grow due to increasing healthcare spending and a rising target patient population. Therefore, the development of healthcare facilities in developing economies in South & Central America, along with a surge in the number of hospitals, would trigger the adoption of LVADs in the coming years. Further, increasing competition among well-established companies compels them to focus on emerging markets, which is expected to create further growth avenues in the South & Central America left ventricular assist device market in the coming years.

South & Central America Left Ventricular Assist Device Market Overview

The South & Central America left ventricular assist device market consists of Brazil, Argentina, and Rest of SAM. Brazil held the largest share of the South & Central America left ventricular assist device market. The flourishing medical tourism sector and government initiatives to create awareness about modern healthcare products are the factors contributing to the left ventricular assist device market growth in South & Central America. Additionally, the rising prevalence of cardiovascular diseases, hypertension, and stroke propels the demand for these devices in the region. According to a report published by the Sociedade Brasileira de Cardiologia (SBC), heart failure (HF) is the major cause of hospitalization related to CVDs in Brazil, and ~1-2% of the population of 50% of these individuals have a decreased ejection fraction. Moreover, most of these patients are reluctant to standard treatment and hospitalization, and the rates of death or rehospitalization within 6 months of the first hospitalization are ~50%. A left ventricular assist device, also known as a continuous flow device, provides a constant flow of blood from the patient's heart to the body. The demand for left ventricular assist devices is substantially lower in Brazil, unlike the numbers reported in developed countries. Despite the evidence of improved survival and quality of life in patients undergoing LVD implantation, the direct and indirect costs for the therapy are still high. In addition, complications associated with the implantation procedure hinder the demand for LVADs in Brazil.

South & Central America Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Left Ventricular Assist Device Market Segmentation

The South & Central America left ventricular assist device market is segmented into type of flow, design, application, and country.

Based on type of flow, the South & Central America left ventricular assist device market is segmented into non-pulsatile and pulsatile flow. The non-pulsatile segment registered the largest market share in 2022.

Based on design, the South & Central America left ventricular assist device market is bifurcated into implantable ventricular assist devices and transcutaneous ventricular assist devices. The implantable ventricular assist devices segment registered the largest market share in 2022.

Based on application, the South & Central America left ventricular assist device market is segmented into destination therapy, bridge to transplantation, bridge to candidacy, and bridge to recovery. The destination therapy segment registered the largest market share in 2022.

The South & Central America left ventricular assist device market, by country, is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2022.

ABIOMED Inc; Abbott Laboratories; Medtronic Plc; LivaNova Plc; and Evaheart Inc are the leading companies operating in the South & Central America left ventricular assist device market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America left ventricular assist device market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America left ventricular assist device market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the left ventricular assist device market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Left Ventricular Assist Device Market - By Type of Flow
    • 1.3.2 South & Central America Left Ventricular Assist Device Market - By Design
    • 1.3.3 South & Central America Left Ventricular Assist Device Market - By Application
    • 1.3.4 South & Central America Left Ventricular Assist Device Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Left Ventricular Assist Device Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Experts Opinion

5. South & Central America Left Ventricular Assist Device Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Heighten Incidence of Target Diseases and Procedures
  • 5.2 Market Restraints
    • 5.2.1 Increase in Product Recalls and Complications Associated with Left Ventricular Assist Devices
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Potential of Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Growing Use of Artificial Intelligence and Machine Learning in LVAD
  • 5.5 Impact Analysis

6. South & Central America Left Ventricular Assist Device Market Analysis

  • 6.1 South & Central America Left Ventricular Assist Device Market Revenue Forecast & Analysis

7. South & Central America Left Ventricular Assist Device Market Analysis - By Type of Flow

  • 7.1 Overview
  • 7.2 South & Central America Left Ventricular Assist Device Market, By Type of Flow 2021 & 2028 (%)
  • 7.3 Pulsatile Flow
    • 7.3.1 Overview
    • 7.3.2 Pulsatile Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Non-Pulsatile
    • 7.4.1 Overview
    • 7.4.2 Non-Pulsatile Market Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Left Ventricular Assist Device Market Analysis - by Design

  • 8.1 Overview
  • 8.2 South & Central America Left Ventricular Assist Device Market, By Design 2021 & 2028 (%)
  • 8.3 Implantable Ventricular Assist Devices
    • 8.3.1 Overview
    • 8.3.2 Implantable Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Transcutaneous Ventricular Assist Devices
    • 8.4.1 Overview
    • 8.4.2 Transcutaneous Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Left Ventricular Assist Device Market - By Application

  • 9.1 Overview
  • 9.2 South & Central America Left Ventricular Assist Device Market, By Application 2021 & 2028 (%)
  • 9.3 Bridge to Transplantation
    • 9.3.1 Overview
    • 9.3.2 Bridge to Transplantation Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Destination Therapy
    • 9.4.1 Overview
    • 9.4.2 Destination Therapy Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Bridge to Recovery
    • 9.5.1 Overview
    • 9.5.2 Bridge to Recovery Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Bridge to Candidacy
    • 9.6.1 Overview
    • 9.6.2 Bridge to Candidacy Market Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Left Ventricular Assist Device Market - Country Analysis

  • 10.1 Overview
    • 10.1.2 South & Central America: Left Ventricular Assist Device Market, by Country, 2022 & 2028 (%)
      • 10.1.2.1 Brazil: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 Brazil Left Ventricular Assist Device Market, By Type of Flow, 2019-2028 (US$ Million)
        • 10.1.2.1.4 Brazil Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.2.1.5 Brazil: Left Ventricular Assist Device, By Application, 2019-2028 (US$ Million)
      • 10.1.2.2 Argentina: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Argentina: Left Ventricular Assist Device Market, By Type of Flow, 2019-2028 (US$ Million)
        • 10.1.2.2.3.1 Argentina: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.2.2.4 Argentina: Left Ventricular Assist Device Market, By Application, 2019-2028 (US$ Million)
      • 10.1.2.3 Rest of the South & Central America: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of the South & Central America Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 Rest of South & Central America: Left Ventricular Assist Device Market, By Type of Flow, 2019-2028 (US$ Million)
        • 10.1.2.3.4 Rest of South & Central America: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.2.3.5 Rest of South & Central America Left Ventricular Assist Device Market, By Application, 2019-2028 (US$ Million)

11. COMPANY PROFILES

  • 11.1 ABIOMED Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Medtronic Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 LivaNova Plc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Terumo Corp
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 BioVentrix Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms